From FAP to B7-H3: What Determines Whether a Radiopharmaceutical Target Successfully Translates to the Clinic?

Name: From FAP to B7-H3: What Determines Whether a Radiopharmaceutical Target Successfully Translates to the Clinic?
Start: 2026-12-01T11:30
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 1 December 2026 · 11:30

From FAP to B7-H3: What Determines Whether a Radiopharmaceutical Target Successfully Translates to the Clinic? was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 1 December 2026 in London, with 1 speaker on record.

Speakers

Kevin Tabury — Speaker Program Pipeline Manager - Head of Innovation & Translational Development Unit, Belgian Nuclear Research Center